Cardiff Oncology Inc. buy krebskrebs
Start price
16.10.23
/
50%
€1.08
Target price
16.10.24
€1.60
Performance (%)
108.26%
Price
23.07.24
€2.25
Summary
This prediction is currently active. With a performance of 108.26% the BUY prediction by krebskrebs is a big success. This prediction currently runs until 16.10.24. The prediction end date can be changed by krebskrebs at any time. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cardiff Oncology Inc. | -5.870% | -5.870% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by krebskrebs for this prediction
In the thread Trovagene diskutieren
Buy mit Kursziel 1,6